Advanced Search

Study Preview



Study Title and Description

Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy.



Key Questions Addressed
1 What are the association between low-calorie sweeteners and health?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy.
Author Heredia D, Terés J, Orteu N, Rodés J.
Country Liver Unit, Hospital Clinic i Provincial, Medical School, Barcelona, Spain.
Year 1988
Numbers Pubmed ID: 3053887

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: LCS-RCT
Design Details
Question... Follow Up Answer Follow-up Answer
Population Adults
  • Comments Comments (
    0
    ) |
Intervention/Exposure Lactitol
  • Comments Comments (
    0
    ) |
Comparator lactulose
  • Comments Comments (
    0
    ) |
LCS vs sugar/ or others 2
  • Comments Comments (
    0
    ) |
Outcomes side effects to lactitol/lactulose; glucose; stool frequency
  • Comments Comments (
    0
    ) |
Study Design RCT-c
  • Comments Comments (
    0
    ) |
Country/Region EU
  • Comments Comments (
    0
    ) |
Age (mean or range) 54.5
  • Comments Comments (
    0
    ) |
Age 54.5
  • Comments Comments (
    0
    ) |
% Male 0.7
  • Comments Comments (
    0
    ) |
BMI NR
  • Comments Comments (
    0
    ) |
Intervention Form Sup or Oral
  • Comments Comments (
    0
    ) |
Sample size 25
  • Comments Comments (
    0
    ) |
Number analyzed (intervention) 20
  • Comments Comments (
    0
    ) |
Number analyzed (control) 0
  • Comments Comments (
    0
    ) |
Baseline health cirrhotic patients with a history of repeated episodes of hepatic encephalopathy
  • Comments Comments (
    0
    ) |
Baseline health (coded) Other
  • Comments Comments (
    0
    ) |
Duration 6 months
  • Comments Comments (
    0
    ) |
Duration (coded) 1 - 6 months
  • Comments Comments (
    0
    ) |
brain 0
  • Comments Comments (
    0
    ) |
glycaemia 1
  • Comments Comments (
    0
    ) |
appetite 0
  • Comments Comments (
    0
    ) |
dietary 0
  • Comments Comments (
    0
    ) |
bodyweight 0
  • Comments Comments (
    0
    ) |
Primary (Most important outcome) glycaemia
  • Comments Comments (
    0
    ) |
Hypotheses/Aim(s) of Study To compare the efficacy and patient acceptability of lactitol vs. lactulose in chronic recurrent portal-systemic encephalopathy (PSE),
  • Comments Comments (
    0
    ) |
Funding source NR
  • Comments Comments (
    0
    ) |
Funding(coded) nr
  • Comments Comments (
    0
    ) |
Internal
  • Comments Comments (
    0
    ) |




Results & Comparisons

No Results found.